Wells Fargo & Company Cytosorbents Corp Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Cytosorbents Corp stock. As of the latest transaction made, Wells Fargo & Company holds 796 shares of CTSO stock, worth $724. This represents 0.0% of its overall portfolio holdings.

Number of Shares

796

Previous 541 47.13%

Holding current value

$724

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.86 - $1.07 $219 - $272	255 Added 47.13%	796 $0
Q4 2023 Feb 09, 2024	BUY	$1.08 - $1.94 $17 - $31	16 Added 3.05%	541 $0
Q3 2023 Nov 13, 2023	SELL	$1.86 - $4.03 $24 - $52	-13 Reduced 2.42%	525 $0
Q2 2023 Aug 15, 2023	BUY	$2.37 - $3.65 $30 - $47	13 Added 2.48%	538 $1,000
Q1 2023 May 12, 2023	BUY	$1.79 - $4.17 $8 - $20	5 Added 0.96%	525 $1,000

Q4 2022 Feb 13, 2023	SELL	$1.03 - $1.63 $4,112 - $6,508	-3,993 Reduced 88.48%	520 $0
Q3 2022 Nov 14, 2022	SELL	$1.39 - $2.46 $52 - $93	-38 Reduced 0.83%	4,513 $6,000
Q2 2022 Aug 12, 2022	SELL	$1.76 - $3.22 $24,094 - $44,081	-13,690 Reduced 75.05%	4,551 $10,000
Q1 2022 May 16, 2022	SELL	$2.88 - $4.23 $42,563 - $62,515	-14,779 Reduced 44.76%	18,241 $59,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $8.11 $95,847 - $191,931	23,666 Added 253.0%	33,020 $139,000
Q3 2021 Nov 15, 2021	BUY	$7.0 - $9.71 $434 - $602	62 Added 0.67%	9,354 $76,000
Q2 2021 Aug 16, 2021	SELL	$7.55 - $9.42 $715,974 - $893,308	-94,831 Reduced 91.08%	9,292 $71,000
Q1 2021 May 13, 2021	SELL	$8.23 - $11.48 $5,234 - $7,301	-636 Reduced 0.61%	104,123 $903,000
Q4 2020 Feb 09, 2021	BUY	$7.65 - $8.98 $12,087 - $14,188	1,580 Added 1.53%	104,759 $835,000
Q3 2020 Nov 05, 2020	BUY	$7.37 - $11.54 $70,435 - $110,287	9,557 Added 10.21%	103,179 $823,000
Q2 2020 Aug 13, 2020	BUY	$6.28 - $10.59 $376,423 - $634,764	59,940 Added 177.96%	93,622 $926,000
Q1 2020 May 14, 2020	BUY	$3.77 - $7.73 $126,981 - $260,361	33,682 New	33,682 $260,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

17.8M

Call Options Held

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $39.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Cytosorbents Corp Transaction History